Factors Associated with Adherence to an End-of-Study Biopsy: Lessons from the Prostate Cancer Prevention Trial (SWOG-Coordinated Intergroup Study S9217)

The Prostate Cancer Prevention Trial (PCPT) was a 7-year randomized, double-blind, placebo-controlled trial of the efficacy of finasteride for the prevention of prostate cancer with a primary outcome of histologically determined prevalence of prostate cancer at the end of 7 years. A systematic model...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancer epidemiology, biomarkers & prevention biomarkers & prevention, 2014-08, Vol.23 (8), p.1638-1648
Hauptverfasser:	GRITZ, Ellen R, ARNOLD, Kathryn B, SZCZEPANEK, Connie, RYAN, Anne, CARLIN, Susie, HILL, Shannon, GOODMAN, Phyllis J, PADBERG, Rose Mary, MINASIAN, Lori M, MEYSKENS, Frank L, THOMPSON, Ian M, MOINPOUR, Carol M, BURTON-CHASE, Allison M, TANGEN, Catherine M, PROBSTFIELD, Jeffrey F, SEE, William A, LIEBER, Michael M, CAGGIANO, Vincent, MOODY-THOMAS, Sarah
Format:	Artikel
Sprache:	eng
Schlagworte:	5-alpha Reductase Inhibitors - therapeutic use Biological and medical sciences Biopsy Double-Blind Method Finasteride - therapeutic use Gynecology. Andrology. Obstetrics Humans Male Male genital diseases Medical sciences Multiple tumors. Solid tumors. Tumors in childhood (general aspects) Nephrology. Urinary tract diseases Patient Compliance - statistics & numerical data Prostatic Neoplasms - prevention & control Research Design ROC Curve Tumors Tumors of the urinary system Urinary tract. Prostate gland
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!